Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Potent, orally active antiulcer agents synthesized at SS Pharm.

May 10, 1999

Infliximab promotes healing of fistulas in patients with Crohn's disease

May 6, 1999

New antiulcer drug expected to reach Spanish market later this year

May 4, 1999

Health Canada expands approved uses of Rebetron

May 3, 1999

Pivotal results demonstrate equal efficacy and better tolerability of Diacol versus NuLYTELY

May 3, 1999

Anti-HBV agents in development at Australian research center

May 3, 1999

SK-951 identified as a potent 5-HT4 agonist/5-HT3 antagonist

April 30, 1999

European CPMP emits positive opinion on Zeffix for chronic HBV

April 27, 1999

U.S. study now under way using artificial liver device incorporating human cells

April 27, 1999

Thalidomide receives orphan drug status for Crohn's disease

April 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...